Cargando…
Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance
INTRODUCTION: Oral preexposure prophylaxis (PrEP) in the form of tenofovir-disoproxil-fumarate/emtricitabine is being implemented in selected sites in South Africa. Addressing outstanding questions on PrEP cost-effectiveness can inform further implementation. METHODS: We calibrated an individual-bas...
Autores principales: | Phillips, Andrew N, Cambiano, Valentina, Johnson, Leigh, Nakagawa, Fumiyo, Homan, Rick, Meyer-Rath, Gesine, Rehle, Thomas, Tanser, Frank, Moyo, Sizulu, Shahmanesh, Maryam, Castor, Delivette, Russell, Elizabeth, Jamieson, Lise, Bansi-Matharu, Loveleen, Shroufi, Amir, Barnabas, Ruanne V, Parikh, Urvi M, Mellors, John W, Revill, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064039/ https://www.ncbi.nlm.nih.gov/pubmed/31851759 http://dx.doi.org/10.1093/infdis/jiz667 |
Ejemplares similares
-
Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
por: Shroufi, Amir, et al.
Publicado: (2019) -
Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa
por: Phillips, Andrew N, et al.
Publicado: (2016) -
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018) -
Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile
por: Phillips, Andrew N., et al.
Publicado: (2016) -
The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
por: Phillips, Andrew N, et al.
Publicado: (2021)